Yes, DMSO can be added directly to the vial. It is recommended to pipet up and down a few times to ensure that all the material is solubilized in DMSO.
M6191
GW9662
>98% (HPLC), PPARγ antagonist, powder
Sinónimos:
2-Chloro-5-nitro-N-phenylbenzamide
Iniciar sesión para ver los precios por organización y contrato.
Seleccione un Tamaño
Cambiar Vistas
| A ustedes/SKU | Disponibilidad | Precio |
|---|---|---|
5 mg | Comprobar disponibilidad del carrito | $75.600 |
25 mg | Comprobar disponibilidad del carrito | $304.000 |
Acerca de este artículo
Fórmula empírica (notación de Hill):
C13H9ClN2O3
Número CAS:
Peso molecular:
276.68
UNSPSC Code:
51111800
PubChem Substance ID:
NACRES:
NA.77
MDL number:
Assay:
>98% (HPLC)
Form:
powder
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarleNombre del producto
GW9662, >98% (HPLC)
Quality Segment
assay
>98% (HPLC)
form
powder
color
white
solubility
DMSO: 26 mg/mL, H2O: insoluble
storage temp.
2-8°C
SMILES string
[O-][N+](=O)c1ccc(Cl)c(c1)C(=O)Nc2ccccc2
InChI
1S/C13H9ClN2O3/c14-12-7-6-10(16(18)19)8-11(12)13(17)15-9-4-2-1-3-5-9/h1-8H,(H,15,17)
InChI key
DNTSIBUQMRRYIU-UHFFFAOYSA-N
Gene Information
human ... PPARG(5468)
Application
Biochem/physiol Actions
GW9662 is an irreversible PPARγ antagonist. GW9662 inhibits connective tissue growth factor and activation of CD36 by IL-4.
GW9662 is an irreversible PPARγ antagonist; inhibits connective tissue growth factor, and activation of CD36 by IL-4.
GW9662 (2-chloro-5-nitrobenzanilide) binds to the ligand binding site of the peroxisome proliferator activated receptor γ (PPARγ) and results in the inhibition of adipocyte differentiation. It favors cell growth suppression in breast cancer cell lines even in the presence of PPARγ agonist rosiglitazone. It stimulates M2c macrophages differentiation and triggers growth arrest-specific 6 (Gas6) expression. GW9662 co treatment with other PPARγ ligands elicits antiproliferative effects on the glioblastoma stem cells and could be a potent therapeutic agent.
Features and Benefits
This compound is featured on the Nuclear Receptors (PPARs) page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.
Legal Information
Sold for research purposes only, under agreement from GlaxoSmithKline
1 of 1
Este artículo | |||
|---|---|---|---|
| description >98% (HPLC) | description ≥98% (HPLC) | description ≥98% (HPLC), white to off-white, powder | description ≥98% (HPLC) |
| form powder | form powder | form powder | form powder |
| assay >98% (HPLC) | assay ≥98% (HPLC) | assay ≥98% (HPLC) | assay ≥98% (HPLC) |
| Quality Level 200 | Quality Level 100 | Quality Level 100 | Quality Level 100 |
| storage temp. 2-8°C | storage temp. 2-8°C | storage temp. 2-8°C | storage temp. 2-8°C |
| solubility DMSO: 26 mg/mL, H2O: insoluble | solubility DMSO: >20 mg/mL | solubility DMSO: ≥10 mg/mL | solubility DMSO: 2 mg/mL, clear |
| color white | color off-white to tan | color white to off-white | color faint yellow to dark orange |
Clase de almacenamiento
11 - Combustible Solids
wgk
WGK 3
Elija entre una de las versiones más recientes:
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
-
GW9662 25mg을 구입해서 사용하고 있는데, 혹시 25mg 정량이 담겨져 오는걸까요? powder를 무게 재기 어려워서 그냥 vial에 바로 DMSO를 추가해서 쓸 수 있을까해서요!
1 answer-
Helpful?
-